A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension

Molecular Vision

Volumn 14, Issue , 2008, Pages 1680-1691

  Lopes de Faria, Jacqueline Medonça ^a   Silva, Kamila Cristina ^a   Boer, Patrícia Aline ^a   Cavalcanti, Tiago Correa ^a   Brunini Rosales, Mariana Aparecida ^a   Ferrari, Ana Luiza ^a   Lopes de Faria, José Butori ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FIBRONECTIN; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CELL COUNT; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE MARKER; HYPERTENSION; IN VIVO STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA CELL; SPONTANEOUSLY HYPERTENSIVE RAT; STEM CELL; WISTAR KYOTO RAT;

AGING; ANIMALS; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; BROMODEOXYURIDINE; CAPILLARY PERMEABILITY; CELL COUNT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERTENSION; IN SITU NICK-END LABELING; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RETINA; STEM CELLS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54749103164     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003; 52:506-11.
2. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998; 102:783-91.
3. Hyvarinen L, Laurinen P, Rovamo J. Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol (Copenh) 1983; 61:94-101.
4. Bresnick GH, Korth K, Groo A, Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Arch Ophthalmol 1984; 102:1307-11.
5. Ghirlanda G, Di Leo MA, Caputo S, Falsini B, Porciatti V, Marietti G, Greco AV. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes 1991, 40:1122-7.
6. Hardy KJ, Lipton J, Scase MO, Foster DH, Scarpello JH. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. Br J Ophthalmol 1992; 76:461-4.
7. Dosso AA, Bonvin ER, Morel Y. Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch Clin Exp Ophthalmol 1996; 234:300-5.
8. Lopes de Faria JM, Katsumi O, Cagliero E, Nathan D, Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 2001; 239:643-8.
9. Stephenson JM, Fuller JH, Viberti G-C, Sjolie A-K, Navalesl R. the EURODIAB IDDM Complications Study Group. Blood pressure, retinopathy and urinary albumin excretion in IDDM: The EURODIAB IDDM Complications Study. Diabetologia 1995; 38:599-603.
10. Wolf G, Schroeder R, Ziyadeh FN, Thaiss F, Zahner G, Stahl RA. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy. Am J Physiol 1997; 273:F348-56.
11. Cip1 is increased inexperimental diabetic nephropathy: potential role in glomerular hypertrophy. J Am Soc Nephrol 1998; 9:986-93.
12. WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney, Int 1999; 56:1691-9.
13. Kip1: role in angiotensin II-mediated, hypertrophy of proximal tubular cells. J Am Soc Nephrol 2000; 11:1387-97.
14. Silveira LA, Bacchi CE, Pinto GA, Lopes de Faria JB. The genetics of hypertension modifies the renal cell replication response induced by experimental diabetes. Diabetes 2002; 51:1529-34.
15. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 1996; 37:258-66.
16. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 2002; 16:242-60.
17. Garner A. Histopathology of diabetic retinopathy in man. Eye 1993; 7:250-3.
18. Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 2001; 44:791-804.
19. Roy S, Sato T, Paryani G, Kao R. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003; 52:1229-34.
20. Ahnlad I, Dooley CM, Thoreson WB, Rogers JA, Afiat S. In vitro analysis of a mammalian retinal progenitor that gives rise to neurons and glia. Brain Res 1999; 831:1-10.
21. Tropepe V, Coles BL, Chiasson BJ, Horsford DJ, Elia AJ, McInnes RR, van der Kooy D. Retinal stem cells in the adult mammalian eye. Science 2000; 287:2032-6.
22. Fischer AJ, Reh TA. Identification of a proliferating marginal zone of retinal progenitors in postnatal chickens. Dev Biol 2000; 220:197-210.
23. Ahmad I, Tang L, Pham H. Identification of neural progenitors in the adult mammalian eye. Biochem Biophys Res Commun 2000; 270:517-21.
24. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60:585-95.
25. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993; 118:489-98.
26. Liu IS, Chen JD, Ploder L, Vidgen D, van der Kooy D, Kalnins VI, McInnes RR. Developmental expression of a novel murine homeobox gene (Chx10): evidence for roles in determination of the neuroretina and inner nuclear layer. Neuron 1994; 13:377-93.
27. Hitchcock PF, Macdonald RE, VanDeRyt JT, Wilson SW. Antibodies against Pax6 immunostain amacrine and ganglion cells and neuronal progenitors, but not rod precursors, in the normal and regenerating retina of the goldfish. J Neurobiol 1996; 29:399-413.
28. Levine EM, Close J, Fero M, Ostrovsky A, Reh TA. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev Biol 2000; 219:299-314.
29. Pinto CC, Silva KC, Biswas SK, Martins N, De Faria JB, De Faria JM. Arterial hypertension exacerbates oxidative stress in early diabetic retinopathy. Free Radic Res 2007; 41:1151-8.
30. Silva KC, Pinto CC, Biswas SK, Lopes de Faria JB, Lopes de Faria JM, Hypertension increases retinal inflammation in experimental diabetes: a possible mechanism for aggravation of diabetic retinopathy by hypertension. Curr Eye Res 2007; 32:533-41.
31. Harms G, Goor H, Koudstaal J, Ley L, Hardonk MJ. Immunohistochemical demonstration of DNA-incorporated 5-bromodeoxyuridine in frozen and plastic embedded sections. Histochemistry 1986; 85:139-43.
32. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72:248-54.
34. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001; 42:789-94.
35. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 1998; 31:1248-54.
36. Yoon YH, Marmor MF. Dextromethorphan protects retina against ischemic injury in vivo. Arch Ophthalmol 1989; 107:409-11.
37. Cao W, Zaharia M, Drumheller A, Casanova C, Lafond G, Brunette JR, Jolicoeur FB. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit. Curr Eye Res 1994; 13:97-102.
38. Alvaro AR, Martins J, Araújo IM, Rosmaninho-Saigado J, Ambrósio AF, Cavadas C. Neuropeptide Y stimulates retinal neural cell proliferation - involvement of nitric oxide. J Neurochem. 2008
39. Lopes de Faria JB, Zoukhri D, Lorenzi M. Mesangial cell abnormalities in spontaneously hypertensive rats before the onset of hypertension. Kidney Int 1997; 52:387-92.
40. Mayer EJ, Carter DA, Ren Y, Hughes EH, Rice CM, Halfpenny CA, Scolding NJ, Dick AD. Neural progenitor cells from postmortem adult human retina. Br J Ophthahnol 2005; 89:102-6.
41. Yang J, Bian W, Gao X, Chen L, Jing N. Nestin expression during mouse eye and lens development. Mech Dev 2000; 94:287-91.
42. Krugliakova EP, Khovriakov AV, Shikhanov NP, McKhann GM II, Vael I, Krugliakov PP, Sosunov AA. Nestin-expressing cells in the human hippocampus. Morfologiia 2004; 126:19-25.
43. Gastinger MJ, Singh RS, Barber AJ, Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 2006; 47:3143-50.
44. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 2000; 16:393-407.
45. King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 1996; 25:255-70.
46. Evans T, Deng DX, Chen S, Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 2000; 49:662-6.
47. Nag S, Kilty DW. Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke 1997; 28:1028-34.
48. Liebetrau M, Burggraf D, Büscher C, Linz W, Hamann GF. Ramipril prevents extracellular matrix accumulation in cerebral microvessels. Neurol Res 2005; 27:477-82.
49. Agabiti-Rosei E. Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy. Drugs 2003; 63:19-29.
50. Awazu M, Omori S, Ishikura K, Hida M, Fujita H. The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14:699-708.